John Finan, director, is a career-long life science business executive leading Baker Tilly’s business development efforts in the life sciences industry sector; he also represents the Baker Tilly life science practice’s organic and national geographic expansion initiative. John joined the Baker Tilly healthcare consulting practice in 2017 leading the commercial enablement practice and supporting the market access team.
John is a former pharmaceutical industry executive with a broad understanding of the functional components of the life science company serving 12 years as a general manager in both corporate and advertising agency sectors; prior spending 14 years learning the industry in functional roles from field sales, hospital and govt sales, medical education, sales management, market access, new product development and regional operations; involved on the periphery, of clinical development, regulatory and legal compliance, finance, accounting, risk management.
His mission is to provide clients and colleagues an objective problem-solving collaborator who: understands the environment life science companies exist within; can view their business challenges to protect and enhance their enterprise valuation from the lens of a general manager, helping them mitigate fear, uncertainty, and doubt to enhance their decision-making confidence to protect value and enhance growth.
Pharmaceutical industry – 26 years internal corporate executive
- 14 years of pharmaceutical industry functional and executive experience serving in roles of increasing responsibility from sales representative to commercial executive leadership
- 12 years as general manager
- Unique experience with office-based and institutional customer channels
Management consulting - life science commercial strategy and operations
- Provided clients advisory to transform business model from clinical-stage organization to commercial-stage company
- Provided clients advisory to secure payer access-coverage-reimbursement with extensive experience in designing pre-launch access and adaptability platforms
- Provided clients advisory for designing asset/portfolio/company level commercial growth initiatives for both fast-tract launch and in-line market expansion
- Led commercial effectiveness advisory practice and functioned as lead advisor for strategic and tactical execution guidance
Functional experience
- Transition to commercial-stage company from clinical-stage organization
- Product development and launch strategy
- Market access strategy - medical and pharmacy payer sectors
- Institutional delivery and DoD/VHA customer channels
- Field execution optimization design and implementation
- Commercial operations/field structure transformations for life science clients
- Risk assessment and commercial compliance assessment and design
- Patient engagement and HUB service strategy and compliant-based design
- Bio New Jersey Industry Group
- Bio New York Industry Group
- Bio Pennsylvania Industry Group
- AdvaMed – Medical Device Industry Trade Group
- University of Rhode Island, Alumni Association – marketing and communication board
